Portal de Oportunidades de Pesquisa – POP Pró-reitoria de Pesquisa

Objetivo: The Therapeutic Development Initiative (TDI) is SKC’s strategic platform for the implementation of its research agenda as well as the vehicle for reviewing and prioritizing submitted research proposals. The TDI’s goal is to support innovative clinical studies that are high on the risk/reward spectrum while, at the same time, investigating these research questions efficiently and effectively. Priority is given to proposals that introduce therapeutic agents and modalities which are first-in-children and have a strong potential to improve treatment outcomes.

Inscrições: durante todo o ano

Mais informações no site.

Objetivo: The corporate funding program is part of PPMD’s GIFTED initiative (Global Investment For Therapeutics to End Duchenne) and is focused on the development of new drugs for Duchenne and Becker muscular dystrophy (the “dystrophinopathies”). The ideal project will yield data that will help a company raise funds from other investors to move the candidate forward to the next stage of clinical development.

Inscrições: durante todo o ano

Mais informações no site.

Objetivo: The RLS Foundation Research Grant Program supports basic and clinical restless legs syndrome (RLS) research. The Foundation challenges the research community to generate novel ideas to unlock the mysteries that will ultimately lead to a cure for this often devastating disease.

Inscrições: durante todo o ano

Mais informações no site.

Objetivo: The NORD Research Grant Program provides seed-money grants to academic scientists for scientific and/or clinical research. The hope is that these studies will ultimately lead to new diagnostics, treatments, and/or cures for rare diseases. NORD’s program provides grants for the study of diseases for which there are few other sources of funding.

Inscrições: durante todo o ano

Mais informações no site.

Objetivo: The NORD Research Grant Program provides seed-money grants to academic scientists for scientific and/or clinical research. The hope is that these studies will ultimately lead to new diagnostics, treatments, and/or cures for rare diseases. NORD’s program provides grants for the study of diseases for which there are few other sources of funding

Inscrições: durante todo o ano

Mais informações no site.

Objetivo: To provide funding up to € 5,000 to grassroots emerging LGBTI projects and initiatives. The support focuses on achieving societal change in order to improve the position of LGBTI people throughout the world, with an emphasis on the most disadvantaged regions and communities. The project also focus on mobilizing and activating the LGBTI community in those challenging contexts.

Inscrições: todos os anos, até 01 de janeiro, 01 de abril, 01 de julho e 01 de outubro

Mais informações no site.

Objetivo: To suport researchers from academia, industry and government who are interested to apply for novel clinical trials in the areas of: Allergy & Asthma; Autoimmune Diseases and Kidney & Liver Transplantation.

Inscrições: durante todo o ano

Mais informações no site.

Objetivo: The purpose of funding clinical research projects is to help us understand how the CDKL5 protein, and lack thereof, affects different organ systems in the human body, and then move quickly into identifying potential therapeutic interventions that will ameliorate symptoms and lead to an improved quality of life for all those affected.

Inscrições: durante todo o ano

Mais informações no site.

Objetivo: To assist investigators requiring a small amount of funding (less than or equal to $5000.00 US) in order to complete a project or facilitate publication. Funds will only be considered for projects that are either completed or near completion.

Inscrições: durante todo o ano

Mais informações no site.

Objetivo: Gateway focuses on transformational science via effective clinical trials—when basic science translates into human testing and clinical practice. We invest in clinical trials to enroll patients at all ages, with all cancer types, whose cancer is at any stage of progress—as long we they have the potential to help people live longer and feel better.

Inscrições: durante todo o ano

Mais informações no site.